AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 105 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DAFNA Capital Management LLC | 625,738 | $5,525,000 | 2.27% |
| Novo Holdings A/S | 3,100,000 | $27,373,000 | 2.17% |
| Nantahala Capital Management | 4,724,211 | $41,715,000 | 1.12% |
| Opus Point Partners Management, LLC | 45,004 | $397,000 | 0.95% |
| Stanley-Laman Group, Ltd. | 301,182 | $2,659,000 | 0.65% |
| Perceptive Advisors | 2,449,521 | $21,629,000 | 0.58% |
| Rubric Capital Management LP | 302,731 | $2,673,000 | 0.28% |
| Abrams Capital Management | 1,119,286 | $9,883,000 | 0.26% |
| Nantahala Capital Management | 851,000 | $7,515,000 | 0.20% |
| Spark Investment Management LLC | 300,000 | $2,649,000 | 0.15% |